# An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

> **NCT02140138** · PHASE2 · TERMINATED · sponsor: **CureVac** · enrollment: 35 (actual)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **BIOLOGICAL:** CV9104
- **DEVICE:** needle free injection device (Tropis®)

## Key facts

- **NCT ID:** NCT02140138
- **Lead sponsor:** CureVac
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for administrative reasons.
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140138, "An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02140138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*